Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.
Drug uptake transporters in antiretroviral therapy.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication.
RNA interference as a tool for exploring HIV-1 robustness.
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.
Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar level.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Deep molecular characterization of HIV-1 dynamics under suppressive HAART.
Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP).